Catalyst Wire Dossier Catalyst Wire Dossier

ASC43F

· Gannex Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASC43F, covering 2024-09-27 to 2024-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of ASC43F, a Fixed Dose Combination Tablet in Healthy Subjects [Phase 1]

See pricing